Birgit Lissenberg-Witte

VU University Amsterdam

De Boelelaan 1105

Amsterdam, ND North Holland 1081 HV

Netherlands

SCHOLARLY PAPERS

1

DOWNLOADS

49

SSRN CITATIONS

0

CROSSREF CITATIONS

0

Scholarly Papers (1)

1.

Health-Related Quality of Life in Transplant Ineligible Newly Diagnosed Multiple Myeloma Patients Treated with Either Thalidomide or Lenalidomide-Based Regimen Until Progression (HOVON-87/NMSG18 Study): A Prospective, Open-Label, Multicenter, Randomized, Phase 3 Study

Number of pages: 89 Posted: 25 Feb 2019
Odense University Hospital - Quality of Life Research Center, VU University Amsterdam, VU University Amsterdam, Erasmus University Rotterdam (EUR) - Clinical Trial Center, South Elvsborg Hospital, University of Copenhagen - Rigshospitalet, Maastricht University, Medical Center, Department of Hematology, Albert Schweitzer Hospital - Department of Internal Medicine, Erasmus University Rotterdam (EUR) - Cancer Institute, Lund University - Skane University Hospital, Martini Ziekenhuis, Tergooi Hospital, Isala Zwolle, Vejle Hospital, Meander Medical Center - Department of Hematology, Forde Central Hospital, Northwest Clinics, Maasstad Hospital, Jeroen Bosch Hospital - Department of Hematology, University of Stavanger - Stavanger University Hospital, Zaans Medisch Centrum, University of Copenhagen - Rigshospitalet, VU University Amsterdam - Department of Hematology, Erasmus University Rotterdam (EUR) - Department of Hematology, Norwegian University of Science and Technology (NTNU), Odense University Hospital and VU University Amsterdam - Department of Hematology
Downloads 49 (711,520)

Abstract:

Loading...

Health-Related Quality of Life, Multiple Myeloma, Clinical Trial